Study type: Human research · Status: Verified against declared source
Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
Journal of medicine and life · 2017
Study scale: Background - Stroke represents one of the most important causes of permanent physical or mental disability.
Abstract only: Open source record
Product or molecular entity relationships
- Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Background - Stroke represents one of the most important causes of permanent physical or mental disability.
Methods
Methods and Results – It was a prospective, randomized, double-blind, placebo-controlled clinical study.
Scale or participants
Background - Stroke represents one of the most important causes of permanent physical or mental disability.
Key findings
Objective - The aim of this trial was to demonstrate the hypothesis that the association of pharmacological treatment with Cerebrolysin to early physical therapy can significantly stimulate the endogenous processes underlying the recovery after an ischemic stroke.
Limitations and uncertainty
Conclusions – Cerebrolysin had a beneficial effect on global neurological status and disability.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.